位置:首页 > 蛋白库 > PUR8_STAHJ
PUR8_STAHJ
ID   PUR8_STAHJ              Reviewed;         431 AA.
AC   Q4L7M3;
DT   14-NOV-2006, integrated into UniProtKB/Swiss-Prot.
DT   02-AUG-2005, sequence version 1.
DT   03-AUG-2022, entry version 124.
DE   RecName: Full=Adenylosuccinate lyase;
DE            Short=ASL;
DE            EC=4.3.2.2 {ECO:0000250|UniProtKB:P0AB89};
DE   AltName: Full=Adenylosuccinase;
DE            Short=ASase;
GN   Name=purB; OrderedLocusNames=SH1043;
OS   Staphylococcus haemolyticus (strain JCSC1435).
OC   Bacteria; Firmicutes; Bacilli; Bacillales; Staphylococcaceae;
OC   Staphylococcus.
OX   NCBI_TaxID=279808;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=JCSC1435;
RX   PubMed=16237012; DOI=10.1128/jb.187.21.7292-7308.2005;
RA   Takeuchi F., Watanabe S., Baba T., Yuzawa H., Ito T., Morimoto Y.,
RA   Kuroda M., Cui L., Takahashi M., Ankai A., Baba S., Fukui S., Lee J.C.,
RA   Hiramatsu K.;
RT   "Whole-genome sequencing of Staphylococcus haemolyticus uncovers the
RT   extreme plasticity of its genome and the evolution of human-colonizing
RT   staphylococcal species.";
RL   J. Bacteriol. 187:7292-7308(2005).
CC   -!- FUNCTION: Catalyzes two reactions in de novo purine nucleotide
CC       biosynthesis. Catalyzes the breakdown of 5-aminoimidazole- (N-
CC       succinylocarboxamide) ribotide (SAICAR or 2-[5-amino-1-(5-phospho-beta-
CC       D-ribosyl)imidazole-4-carboxamido]succinate) to 5-aminoimidazole-4-
CC       carboxamide ribotide (AICAR or 5-amino-1-(5-phospho-beta-D-
CC       ribosyl)imidazole-4-carboxamide) and fumarate, and of adenylosuccinate
CC       (ADS or N(6)-(1,2-dicarboxyethyl)-AMP) to adenosine monophosphate (AMP)
CC       and fumarate. {ECO:0000250|UniProtKB:P0AB89}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=N(6)-(1,2-dicarboxyethyl)-AMP = AMP + fumarate;
CC         Xref=Rhea:RHEA:16853, ChEBI:CHEBI:29806, ChEBI:CHEBI:57567,
CC         ChEBI:CHEBI:456215; EC=4.3.2.2;
CC         Evidence={ECO:0000250|UniProtKB:P0AB89};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:16854;
CC         Evidence={ECO:0000250|UniProtKB:P0AB89};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(2S)-2-[5-amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-
CC         carboxamido]succinate = 5-amino-1-(5-phospho-beta-D-
CC         ribosyl)imidazole-4-carboxamide + fumarate; Xref=Rhea:RHEA:23920,
CC         ChEBI:CHEBI:29806, ChEBI:CHEBI:58443, ChEBI:CHEBI:58475; EC=4.3.2.2;
CC         Evidence={ECO:0000250|UniProtKB:P0AB89};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:23921;
CC         Evidence={ECO:0000250|UniProtKB:P0AB89};
CC   -!- PATHWAY: Purine metabolism; AMP biosynthesis via de novo pathway; AMP
CC       from IMP: step 2/2.
CC   -!- PATHWAY: Purine metabolism; IMP biosynthesis via de novo pathway; 5-
CC       amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide from 5-amino-1-(5-
CC       phospho-D-ribosyl)imidazole-4-carboxylate: step 2/2.
CC   -!- SUBUNIT: Homodimer and homotetramer. Residues from neighboring subunits
CC       contribute catalytic and substrate-binding residues to each active site
CC       (By similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the lyase 1 family. Adenylosuccinate lyase
CC       subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AP006716; BAE04352.1; -; Genomic_DNA.
DR   RefSeq; WP_011275349.1; NC_007168.1.
DR   AlphaFoldDB; Q4L7M3; -.
DR   SMR; Q4L7M3; -.
DR   STRING; 279808.SH1043; -.
DR   EnsemblBacteria; BAE04352; BAE04352; SH1043.
DR   KEGG; sha:SH1043; -.
DR   eggNOG; COG0015; Bacteria.
DR   HOGENOM; CLU_030949_0_1_9; -.
DR   OMA; ASSCEKI; -.
DR   OrthoDB; 347727at2; -.
DR   UniPathway; UPA00074; UER00132.
DR   UniPathway; UPA00075; UER00336.
DR   Proteomes; UP000000543; Chromosome.
DR   GO; GO:0070626; F:(S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido) succinate lyase (fumarate-forming) activity; IEA:UniProtKB-EC.
DR   GO; GO:0004018; F:N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity; IEA:UniProtKB-EC.
DR   GO; GO:0044208; P:'de novo' AMP biosynthetic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0006189; P:'de novo' IMP biosynthetic process; IEA:UniProtKB-UniPathway.
DR   Gene3D; 1.10.275.10; -; 1.
DR   InterPro; IPR019468; AdenyloSucc_lyase_C.
DR   InterPro; IPR024083; Fumarase/histidase_N.
DR   InterPro; IPR020557; Fumarate_lyase_CS.
DR   InterPro; IPR000362; Fumarate_lyase_fam.
DR   InterPro; IPR022761; Fumarate_lyase_N.
DR   InterPro; IPR008948; L-Aspartase-like.
DR   InterPro; IPR004769; Pur_lyase.
DR   Pfam; PF10397; ADSL_C; 1.
DR   Pfam; PF00206; Lyase_1; 1.
DR   PRINTS; PR00149; FUMRATELYASE.
DR   SMART; SM00998; ADSL_C; 1.
DR   SUPFAM; SSF48557; SSF48557; 1.
DR   TIGRFAMs; TIGR00928; purB; 1.
DR   PROSITE; PS00163; FUMARATE_LYASES; 1.
PE   3: Inferred from homology;
KW   Lyase; Purine biosynthesis.
FT   CHAIN           1..431
FT                   /note="Adenylosuccinate lyase"
FT                   /id="PRO_0000259984"
FT   ACT_SITE        141
FT                   /note="Proton donor/acceptor"
FT                   /evidence="ECO:0000250|UniProtKB:P0AB89"
FT   ACT_SITE        262
FT                   /note="Proton donor/acceptor"
FT                   /evidence="ECO:0000250|UniProtKB:P0AB89"
FT   BINDING         4..5
FT                   /ligand="N(6)-(1,2-dicarboxyethyl)-AMP"
FT                   /ligand_id="ChEBI:CHEBI:57567"
FT                   /evidence="ECO:0000250|UniProtKB:P0AB89"
FT   BINDING         67..69
FT                   /ligand="N(6)-(1,2-dicarboxyethyl)-AMP"
FT                   /ligand_id="ChEBI:CHEBI:57567"
FT                   /evidence="ECO:0000250|UniProtKB:P0AB89"
FT   BINDING         93..94
FT                   /ligand="N(6)-(1,2-dicarboxyethyl)-AMP"
FT                   /ligand_id="ChEBI:CHEBI:57567"
FT                   /evidence="ECO:0000250|UniProtKB:P0AB89"
FT   BINDING         212
FT                   /ligand="N(6)-(1,2-dicarboxyethyl)-AMP"
FT                   /ligand_id="ChEBI:CHEBI:57567"
FT                   /evidence="ECO:0000250|UniProtKB:P0AB89"
FT   BINDING         263
FT                   /ligand="N(6)-(1,2-dicarboxyethyl)-AMP"
FT                   /ligand_id="ChEBI:CHEBI:57567"
FT                   /evidence="ECO:0000250|UniProtKB:P0AB89"
FT   BINDING         268..270
FT                   /ligand="N(6)-(1,2-dicarboxyethyl)-AMP"
FT                   /ligand_id="ChEBI:CHEBI:57567"
FT                   /evidence="ECO:0000250|UniProtKB:P0AB89"
FT   BINDING         276
FT                   /ligand="N(6)-(1,2-dicarboxyethyl)-AMP"
FT                   /ligand_id="ChEBI:CHEBI:57567"
FT                   /evidence="ECO:0000250|UniProtKB:P0AB89"
FT   BINDING         307..311
FT                   /ligand="N(6)-(1,2-dicarboxyethyl)-AMP"
FT                   /ligand_id="ChEBI:CHEBI:57567"
FT                   /evidence="ECO:0000250|UniProtKB:P0AB89"
SQ   SEQUENCE   431 AA;  49894 MW;  88C7A78DF1E97747 CRC64;
     MIDRYSREEM ANIWTDQNRY EAWLEVEILA CEAWSELGHI PKEDVKKIRQ NAKVDVKRAQ
     EIEQETRHDV VAFTRQVSET LGDERKWVHY GLTSTDVVDT ALSYVIKQAN EIIEKDIERF
     IKVLEEKAKN YKYTLMMGRT HGVHAEPTTF GVKMALWYTE MKRNLKRFKE VRKEIEVGKM
     SGAVGTFANI PPEIEQYVCD HLGIDTASVS TQTLQRDRHA YYIATLALVA TSLEKFAVEI
     RNLQKTETRE VEEAFAKGQK GSSAMPHKRN PIGSENITGI SRVIRGYITT AYENVPLWHE
     RDISHSSAER IMLPDVTIAL DYALNRFTNI VDRLTVFEDN MRNNIDKTFG LIFSQRVLLA
     LINKGMVREE AYDRVQPKAM ESWETKTPFR QLIEKDESIT NVLSKEELDE CFNPEHHLNQ
     VDTIFKRAGL E
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024